Similarly, we also observed a decreasing level of Bcl-2 in Fyn deficiency and Lj-1-60 treated melanoma cells, which may explain why inactivated Stat3 cannot translocate into the nucleus and bind to the Bcl-2 promoter, thus decreasing the transcription of Bcl-2. Here, FYN is linked to melanoma.